Skip to main content
Fig. 5 | International Journal of Retina and Vitreous

Fig. 5

From: Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial

Fig. 5

Spectral-domain OCT B-scan and angiography c-scan pictures from patient number 1. a. B-scan OCT at baseline showing isolated and coalescent drusen, junctional subretinal hyperreflective material, and intraretinal fluid. b. OCT-A picture showing two hyperreflective spots (yellow arrows) in the avascular complex slab, suggestive of choroidal neovascularization sites or foci. c. B-scan OCT at 12 week follow-up visit showing regression of intraretinal fluid and some junctional subretinal hyperreflective material. d. OCT-A picture showing discrete reduction of hyperreflectivity in temporal inferior CNV, while there was maintenance of flow in the inferior CNV focus

Back to article page